Cargando…
Rapid and temporary improvement of depression and anxiety observed following niraparib administration: a case report
BACKGROUND: Cancer patients are disproportionately affected by generalized anxiety and major depression. For many, current treatments for these conditions are ineffective. In this case report, we present a serendipitous case of anxiety and depression improvement following administration of the poly...
Autores principales: | Jewett, Benjamin E., Miller, Merry N., Ligon, Libby A., Carter, Zachary, Mohammad, Ibrahim, Ordway, Gregory A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7161116/ https://www.ncbi.nlm.nih.gov/pubmed/32295563 http://dx.doi.org/10.1186/s12888-020-02590-4 |
Ejemplares similares
-
Niraparib for ovarian cancer
Publicado: (2021) -
Rucaparib and Niraparib in Advanced Ovarian Cancer
por: Redelico, Tyler
Publicado: (2019) -
A case of niraparib PARP-Inhibitor induced Sweet Syndrome in gynecologic cancer
por: Badiner, Nora, et al.
Publicado: (2023) -
Pharmacokinetics and safety of niraparib in patients with moderate hepatic impairment
por: Akce, Mehmet, et al.
Publicado: (2021) -
The efficacy and safety of niraparib for ovarian cancer: a single-center observational study from China
por: Ni, Jing, et al.
Publicado: (2021)